One particular study is known by which PKCθ has been described to promote growth factor independent growth, anoikis resistance, and migration (in 3-D Matrigel and breast primary tumor xenografts) in a subset of triple negative breast cancer (TNBC) cells [22]. This evidence concerns the gene PRRT2 and neoplasm.